Summary

The Global Molecular Biology Enzymes & Kits & Reagents Market, valued at approximately USD 22.79 billion in 2024, is projected to expand at an impressive CAGR of 14.20% between 2025 and 2035. As the beating heart of modern life sciences, these tools empower researchers to decode genetic blueprints, engineer novel biological systems, and push the boundaries of molecular diagnostics. The industry’s rapid ascent is underpinned by a confluence of driving forces—accelerating adoption of next-generation sequencing (NGS), expanding synthetic biology applications, and the urgent demand for precision medicine solutions. From enabling faster PCR amplification to facilitating highly sensitive epigenetic mapping, the market’s product portfolio is becoming increasingly diverse and technologically advanced, meeting the growing need for reproducibility, sensitivity, and throughput in molecular research. The integration of AI-driven analytics, automated liquid handling systems, and cloud-based data sharing is further transforming how researchers use these reagents and enzymes in daily workflows.
The surging global investment in genomics research, coupled with large-scale population sequencing initiatives, is fuelling unprecedented demand for high-quality enzymes, kits, and reagents. Their role in PCR-based pathogen detection—particularly highlighted during the COVID-19 pandemic—has shifted from being primarily research-focused to encompassing front-line diagnostic applications. According to industry data, the global sequencing output has doubled every 12 months in recent years, driving a parallel spike in reagent consumption. Moreover, breakthroughs in enzyme engineering, such as thermostable polymerases and high-fidelity reverse transcriptases, are enabling more complex assays and expanding the capabilities of synthetic biology. However, challenges such as stringent regulatory approvals, high production costs, and supply chain constraints remain hurdles to wider adoption, even as technological innovations promise to mitigate these issues in the near term.
From a geographical standpoint, North America held the largest market share in 2024, propelled by its sophisticated research infrastructure, strong academic–industry collaborations, and extensive biotechnology funding ecosystem. The U.S., home to global leaders in genomics and molecular diagnostics, continues to set the pace with its cutting-edge R&D initiatives and advanced healthcare adoption of molecular technologies. Europe follows closely, led by countries such as Germany, the UK, and France, where investments in precision oncology and infectious disease research are substantial. Meanwhile, the Asia Pacific region is emerging as the fastest-growing market over the forecast period, driven by rapidly expanding biotech sectors in China, Japan, and India. Government-backed genome projects, surging demand for biopharmaceutical production, and a rising prevalence of chronic diseases are fuelling uptake of molecular biology products. The region’s push to localize reagent manufacturing and establish advanced research hubs is expected to further solidify its position in the global landscape.
Major market players included in this report are:
• Thermo Fisher Scientific Inc.
• Merck KGaA
• New England Biolabs, Inc.
• Agilent Technologies, Inc.
• Promega Corporation
• Illumina, Inc.
• Bio-Rad Laboratories, Inc.
• QIAGEN N.V.
• Roche Diagnostics
• Takara Bio Inc.
• Enzo Biochem Inc.
• Jena Bioscience GmbH
• LGC Biosearch Technologies
• PerkinElmer Inc.
• Epicentre Technologies Corporation
Global Molecular Biology Enzymes & Kits & Reagents Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period - 2025-2035
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent up to 8 analysts’ working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segments of the market are explained below:
By Product:
• Kits
• Reagents
• Enzyme
By Application:
• PCR
• Sequencing
• Epigenetic
• Synthetic Biology
By End user:
• Research Institutes
• Pharma & Biotech Company
• Hospitals
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa
Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1. Global Molecular Biology Enzymes, Kits & Reagents Market Report Scope & Methodology
1.1. Research Objective
1.2. Research Methodology
1.2.1. Forecast Model
1.2.2. Desk Research
1.2.3. Top Down and Bottom-Up Approach
1.3. Research Attributes
1.4. Scope of the Study
1.4.1. Market Definition
1.4.2. Market Segmentation
1.5. Research Assumption
1.5.1. Inclusion & Exclusion
1.5.2. Limitations
1.5.3. Years Considered for the Study
Chapter 2. Executive Summary
2.1. CEO/CXO Standpoint
2.2. Strategic Insights
2.3. ESG Analysis
2.4. Key Findings
Chapter 3. Global Molecular Biology Enzymes, Kits & Reagents Market Forces Analysis
3.1. Market Forces Shaping The Global Molecular Biology Enzymes, Kits & Reagents Market (2024–2035)
3.2. Drivers
3.2.1. Rising adoption of next-generation sequencing (NGS) and large-scale genome mapping initiatives
3.2.2. Increasing demand for personalized medicine and precision diagnostics
3.2.3. Advancements in enzyme engineering, automation, and AI-powered assay design
3.2.4. Expansion of decentralized and point-of-care molecular diagnostics
3.3. Restraints
3.3.1. Stringent regulatory requirements for product approval and compliance
3.3.2. High production costs of high-quality enzymes and reagents
3.3.3. Supply chain vulnerabilities and raw material constraints
3.4. Opportunities
3.4.1. Growing investments in genomics research and synthetic biology
3.4.2. Expansion of biopharmaceutical manufacturing in emerging markets
3.4.3. Development of localized manufacturing hubs to improve supply resilience
Chapter 4. Global Molecular Biology Enzymes, Kits & Reagents Industry Analysis
4.1. Porter’s 5 Forces Model
4.1.1. Bargaining Power of Buyer
4.1.2. Bargaining Power of Supplier
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Forecast Model (2024–2035)
4.3. PESTEL Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top Investment Opportunities
4.5. Top Winning Strategies (2025)
4.6. Market Share Analysis (2024–2025)
4.7. Global Pricing Analysis and Trends 2025
4.8. Analyst Recommendation & Conclusion
Chapter 5. Global Molecular Biology Enzymes, Kits & Reagents Market Size & Forecasts by Product 2025–2035
5.1. Market Overview
5.2. Global Molecular Biology Enzymes, Kits & Reagents Market Performance – Potential Analysis (2025)
5.3. Kits
5.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
5.3.2. Market size analysis, by region, 2025–2035
5.4. Reagents
5.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
5.4.2. Market size analysis, by region, 2025–2035
5.5. Enzyme
5.5.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
5.5.2. Market size analysis, by region, 2025–2035
Chapter 6. Global Molecular Biology Enzymes, Kits & Reagents Market Size & Forecasts by Application 2025–2035
6.1. Market Overview
6.2. Global Molecular Biology Enzymes, Kits & Reagents Market Performance – Potential Analysis (2025)
6.3. PCR
6.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
6.3.2. Market size analysis, by region, 2025–2035
6.4. Sequencing
6.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
6.4.2. Market size analysis, by region, 2025–2035
6.5. Epigenetic
6.5.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
6.5.2. Market size analysis, by region, 2025–2035
6.6. Synthetic Biology
6.6.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
6.6.2. Market size analysis, by region, 2025–2035
Chapter 7. Global Molecular Biology Enzymes, Kits & Reagents Market Size & Forecasts by End User 2025–2035
7.1. Market Overview
7.2. Global Molecular Biology Enzymes, Kits & Reagents Market Performance – Potential Analysis (2025)
7.3. Research Institutes
7.3.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
7.3.2. Market size analysis, by region, 2025–2035
7.4. Pharma & Biotech Company
7.4.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
7.4.2. Market size analysis, by region, 2025–2035
7.5. Hospitals
7.5.1. Top Countries Breakdown Estimates & Forecasts, 2024–2035
7.5.2. Market size analysis, by region, 2025–2035
Chapter 8. Global Molecular Biology Enzymes, Kits & Reagents Market Size & Forecasts by Region 2025–2035
8.1. Global Molecular Biology Enzymes, Kits & Reagents Market, Regional Market Snapshot
8.2. Top Leading & Emerging Countries
8.3. North America Molecular Biology Enzymes, Kits & Reagents Market
8.3.1. U.S.
8.3.1.1. Product breakdown size & forecasts, 2025–2035
8.3.1.2. Application breakdown size & forecasts, 2025–2035
8.3.1.3. End User breakdown size & forecasts, 2025–2035
8.3.2. Canada
8.3.2.1. Product breakdown size & forecasts, 2025–2035
8.3.2.2. Application breakdown size & forecasts, 2025–2035
8.3.2.3. End User breakdown size & forecasts, 2025–2035
8.4. Europe Molecular Biology Enzymes, Kits & Reagents Market
8.4.1. UK
8.4.1.1. Product breakdown size & forecasts, 2025–2035
8.4.1.2. Application breakdown size & forecasts, 2025–2035
8.4.1.3. End User breakdown size & forecasts, 2025–2035
8.4.2. Germany
8.4.3. France
8.4.4. Spain
8.4.5. Italy
8.4.6. Rest of Europe (ROE)
(Each country with same three sub-breakdowns as above)
8.5. Asia Pacific Molecular Biology Enzymes, Kits & Reagents Market
8.5.1. China
8.5.2. India
8.5.3. Japan
8.5.4. Australia
8.5.5. South Korea
8.5.6. Rest of Asia Pacific (RoAPAC)
(Each country with same three sub-breakdowns as above)
8.6. Latin America Molecular Biology Enzymes, Kits & Reagents Market
8.6.1. Brazil
8.6.2. Mexico
(Each country with same three sub-breakdowns as above)
8.7. Middle East & Africa Molecular Biology Enzymes, Kits & Reagents Market
8.7.1. UAE
8.7.2. Saudi Arabia
8.7.3. South Africa
8.7.4. Rest of Middle East & Africa
(Each country with same three sub-breakdowns as above)
Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Thermo Fisher Scientific Inc.
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Financial Performance (Subject to Data Availability)
9.2.5. Product/Services Port
9.2.6. Recent Development
9.2.7. Market Strategies
9.2.8. SWOT Analysis
9.3. Agilent Technologies, Inc.
9.4. New England Biolabs, Inc.
9.5. Merck KGaA
9.6. Promega Corporation
9.7. Illumina, Inc.
9.8. Bio-Rad Laboratories, Inc.
9.9. QIAGEN N.V.
9.10. Roche Diagnostics
9.11. Takara Bio Inc.
9.12. Enzo Biochem Inc.
9.13. Jena Bioscience GmbH
9.14. LGC Biosearch Technologies
9.15. PerkinElmer Inc.
9.16. Epicentre Technologies Corporation